NASDAQ
Phathom Pharmaceuticals, Inc. (PHAT) has a fcf yield of -13.79% as of Friday, May 29, 2026. This represents a 59.40% increase compared to its 12-month average of -33.96%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.